The ZBTB7A mutation may collaborate with the RUNX1-RUNX1T1 fusion gene in two ways and could be a new target to treat acute myeloid leukemia (AML) (Figure 1). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.